Search Results 1971-1980 of 19340 for prostate cancer

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Radiation Oncologist. Phoenix, AZ. Areas of focus: Proton therapy, Head and neck cancer, Prostate cancer, Bladder cancer, Testicular cancer, Breast cancer ...

  2. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

    Prostate cancer with a Gleason score < 7 with undetectable prostate specific antigen (PSA) over 12 months;; Treated medullary or papillary thyroid cancer; ...

  3. First in Human Study of TORL-3-600 in Participants With Advanced Cancer - Mayo Clinic

    Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... prostate cancer with a Gleason score less than or equal to 6, are ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Winston Tan, M.D.. Oncologist; Hematologist. Jacksonville, FL. Areas of focus: Kidney cancer, Prostate cancer, Bladder cancer, Melanoma, Breast cancer ...

  5. Testosterone (transdermal route) - Mayo Clinic

    Prostate cancer, known or suspected—Should not be used in patients with these conditions. Heart disease (eg, congestive heart failure) or; Kidney disease or ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    ... Prostate cancer, Bladder cancer, Testicular cancer, Ure...thral cancer, Breast cancer, Endometrial cancer, Cervical cancer. Show more areas of focus for ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    ... Prostate cancer, Bladder cancer, Testicular cancer, Ure...thral cancer, Breast cancer, Endometrial cancer, Cervical cancer. Show more areas of focus for ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    ... Prostate cancer, Bladder cancer, Testicular cancer, Ure...thral cancer, Breast cancer, Endometrial cancer, Cervical cancer. Show more areas of focus for ...

  9. Publications - Lyndsay D. Viers, M.D. - Mayo Clinic

    Prostate cancer post-treatment follow-up and recurrence evaluation. Abdom Radiol (NY). 2016 May; 41 (5):862-76. View PubMed; Viers BR, Viers LD, Hull NC ...

  10. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. (PSMA-DC) - Mayo Clinic

    Histologically confirmed prostate cancer prior to randomization. 6. Participants must have biochemically recurrent disease after definitive treatment to